These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3158631)
21. Synthesis and antibacterial action of 3',6'-disubstituted spectinomycins. Dharuman S; Phelps GA; Dunn CM; Wilt LA; Murphy PA; Lee RB; Snoke HE; Selchow P; Haldimann K; Böttger EC; Hobbie SN; Sander P; Lee RE J Antibiot (Tokyo); 2024 Sep; 77(9):577-588. PubMed ID: 38890386 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro activity of new semi-synthetic coumermycin analogs: chemical modification at the C-3 amide. Ueda Y; Chuang JM; Crast LB; Partyka RA J Antibiot (Tokyo); 1989 Sep; 42(9):1379-92. PubMed ID: 2793593 [TBL] [Abstract][Full Text] [Related]
23. The production of dihydrospectinomycin by Streptomyces spectabilis. Hoeksema H; Knight JC J Antibiot (Tokyo); 1975 Mar; 28(3):240-1. PubMed ID: 123898 [No Abstract] [Full Text] [Related]
24. Preparation of 7-deoxyspectinomycin and 7-deoxy-8-epi-4(R)-dihydrospectinomycin. Foley L; Lin JT; Weigele M J Antibiot (Tokyo); 1979 Apr; 32(4):418-9. PubMed ID: 157346 [No Abstract] [Full Text] [Related]
25. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin. Gismondo MR; Chisari G; Lo Bue AM Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841 [TBL] [Abstract][Full Text] [Related]
26. Spectinomycin interacts specifically with the residues G1064 and C1192 in 16S rRNA, thereby potentially freezing this molecule into an inactive conformation. Brink MF; Brink G; Verbeet MP; de Boer HA Nucleic Acids Res; 1994 Feb; 22(3):325-31. PubMed ID: 8127669 [TBL] [Abstract][Full Text] [Related]
27. In-vitro activity of trospectromycin against gram-positive cocci. Beam TR; Gorzynski EA; Rotstein C; Amsterdam D J Antimicrob Chemother; 1995 Nov; 36(5):874-8. PubMed ID: 8626271 [No Abstract] [Full Text] [Related]
28. In vitro activity of a new antibacterial drug, trospectomycin sulphate (U-63,366F), against Bacteroides strains isolated from the vagina. Testore GP; Terranova L; Salanitro A; Sordillo P; Foli A; Giacomello F; Andreoni M Chemotherapy; 1993; 39(2):124-7. PubMed ID: 8458245 [TBL] [Abstract][Full Text] [Related]
29. In-vitro activity of trospectomycin, a new aminocyclitol antibiotic, against multidrug-resistant Enterococcus faecium. Mobarakai N; Landman D; Quale JM J Antimicrob Chemother; 1994 Feb; 33(2):319-21. PubMed ID: 8182013 [No Abstract] [Full Text] [Related]
30. In vitro activity of trospectomycin against methicillin-resistant Staphylococcus aureus and enterococci. Flournoy DJ; Koester JF Methods Find Exp Clin Pharmacol; 1992; 14(6):483-4. PubMed ID: 1469958 [No Abstract] [Full Text] [Related]
31. In-vitro activity of trospectomycin against enterococci isolated from blood and other clinical materials. Watanakunakorn C J Antimicrob Chemother; 1991 Jun; 27(6):873-5. PubMed ID: 1834622 [No Abstract] [Full Text] [Related]
32. A novel carbapenem antibiotic, SM-7338 structure-activity relationships. Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404 [TBL] [Abstract][Full Text] [Related]
33. 3-amino-3-demethoxyfortimicin A and the C-2 epimeric-2-amino-3-O-demethyl-2-deoxyfortimicins A. Tadanier J; Hallas R; Holms J; Freiberg LA; Bacino D J Antibiot (Tokyo); 1983 Mar; 36(3):267-75. PubMed ID: 6833146 [TBL] [Abstract][Full Text] [Related]